Navigation Links
Morphotek(R), Inc. Announces FDA Acceptance of Investigational New Drug Application for MORAb-004, a Monoclonal Antibody for the Treatment of Solid Tumors
Date:6/9/2009

Antibody Targets Endosialin, a Protein Widely Expressed on Tumors and Tumor Blood Vessel Cells

EXTON, Pa., June 9 /PRNewswire/ -- Morphotek(R), Inc., a subsidiary of Eisai Corporation of North America, announced that the U.S. Food and Drug Administration (FDA) cleared its investigational new drug (IND) application to study MORAb-004 in the treatment of patients with solid tumors. MORAb-004 targets endosialin, a protein expressed on cells associated with tumors and tumor blood vessel cells. The IND became effective 30 days after its initial submission to the FDA by Morphotek.

Some researchers have demonstrated that endosialin, the target of MORAb-004, is necessary for the development of new blood vessels (a process called angiogenesis). New blood vessels are required to provide blood flow to tumors for growth. Endosialin is expressed on pericytes which are cells that surround the smallest blood vessels and are needed for the survival, migration and differentiation of small blood vessels.

"The mechanism of action of MORAb-004, the concept of disturbing the tumor environment, is novel in cancer therapy," said Martin D. Phillips, M.D., Morphotek's Chief Medical Officer. "We are pleased to be carrying out the Phase I study with one of the world's leading health care institutions to focus on treating solid tumors and continue clinical development of this potential new treatment."

MORAb-004, which targets the growth of endosialin-expressing cells in tumor blood vessels, will be used to treat patients with solid tumors. Other anti-angiogenesis drugs target tumor endothelial cells, rather than pericytes. Treatment with MORAb-004 offers an alternative means to suppress tumor angiogenesis and growth.

"MORAb-004 is another unique therapeutic antibody being developed by our company that is believed to inhibit tumor growth via a disease-associated pathway identified and studied by o
'/>"/>

SOURCE Morphotek, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Morphotek(R), Inc. and Eisai Corporation of North America Announce FDA Special Protocol Assessment (SPA) for Phase III Trial Evaluating Farletuzumab in Relapsed Ovarian Cancer
2. Abbott Announces New EAS(R) Myoplex(R) Strength Formula Nutrition Shake and Debuts Bottle Packaging
3. Life Spine Announces Appointment of Todd Fanning as Vice President of Sales
4. CareFusion Announces Board of Directors, Progress on Alaris Consent Decree
5. ThinIdentity(TM) Announces Two New Board Members
6. Brookdale Announces Completion of Follow-On Offering
7. Scientx Groupe, S.A. Announces Completion of Credit Facility and Incremental Capital Infusion
8. ViroPharma Announces Appointment of Frank Baldino, Jr., Ph.D. to Board of Directors
9. Oxygen Biotherapeutics, Inc. Announces Private Placement Financing Agreement and Offer to Acquire Warrants
10. Microbridge Technologies Announces Micro-Flow Differential Pressure Sensors for Medical Respiration and Industrial HVAC Applications
11. DATATRAK Announces New Products and Features at DIA San Diego
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/30/2014)... Saturday 30 August 2014: The first comprehensive ESC ... presented at ESC Congress 2014 by Task Force Chairpersons ... , The "2014 ESC Guidelines on the diagnosis and ... European Heart Journal (1) and on ... recommendations were published in 2001 but they were restricted ...
(Date:8/30/2014)... Saturday 30 August 2014: A new sudden ... identifies candidates for implantable cardioverter defibrillators (ICDs) in ... ESC Congress by Task Force Chairperson Professor Perry ... Diagnosis and Management of Hypertrophic Cardiomyopathy" are published ... (1) and on the ESC Website. Previous ...
(Date:8/29/2014)... Daily Gossip writes in its review that this is actually ... method promises to teach readers how to eliminate the need ... sources for the production of energy. , Some of ... power. , The Home Made Energy review indicates that ... this is an online guide that will teach its users ...
(Date:8/29/2014)... (PRWEB) August 30, 2014 Indosoft, ... center software, announces the release of its most advanced ... a number of new features as well as updates ... software. , Q-Suite functionality on the presentation side ... TinyMCE into the script builder. This WYSIWYG ...
(Date:8/29/2014)... (PRWEB) August 30, 2014 AGH Healthy ... the Doctors in Delaware at Atlantic General ... free health-related services. In addition to no-cost blood pressure ... offers first aid care at local sports tournaments. ... other medical staff provide free disease management and falls ...
Breaking Medicine News(10 mins):Health News:First comprehensive ESC Guidelines on aortic diseases published 2Health News:First comprehensive ESC Guidelines on aortic diseases published 3Health News:Sudden death predictor identifies ICD candidates in new ESC Guidelines 2Health News:Home Made Energy Review Exposes Simple Method to Access Alternative Energy Sources 2Health News:Indosoft Releases Q-Suite 5.7.7 2Health News:Doctors in Delaware from Atlantic General Hospital Offer No-Cost Services to Area Residents 2Health News:Doctors in Delaware from Atlantic General Hospital Offer No-Cost Services to Area Residents 3
... , , WASHINGTON , Jan. ... which shows small businesses continue to struggle under the lagging economy ... decreases in revenue over the past 12 months rose to its ... to get adequate financing for their business. Despite a very dismal ...
... ... charter flight from JFK to Port-au-Prince to bring doctors and relief workers to help ... ... flight organized by the Church of Scientology carried 126 doctors, nurses, emergency medical technicians ...
... , Jan. 19 A shipment of Lutheran World ... Windsor, Md. , today, to be distributed to Haitian earthquake survivors. ... of 650 health kits and 1500 layettes, the first of multiple ... valued at nearly $500,000 and plans to send more ...
... , , PELLA, Iowa , Jan. 19 ... help those in the design, building and remodeling industries build their business ... will spring into action Feb. 2 through May 13 as ... cities. During the free events, attendees can obtain continuing education credits, learn ...
... Kris Freeman hopes for first U.S. cross-country medal since 1976; health ... Kris Freeman is back in the hunt for an ... ski team following a disappointing finish at the 2006 Games in Torino, ... at the 2010 Games in February, suffers from type 1 diabetes, a form ...
... at the University of California, San Diego School of Medicine ... which gliomas, a deadly type of brain tumor, can evade ... growth factor receptor (EGFR),that is crucial for tumor growth. In ... mutation is important not only to initiate the tumor, but ...
Cached Medicine News:Health News:NSBA 2009 Year-End Economic Report: Small Businesses Still Struggling 2Health News:NSBA 2009 Year-End Economic Report: Small Businesses Still Struggling 3Health News:Scientology-Sponsored Charter Flight Brings Medical and Spiritual Aid to Haiti 2Health News:Lutheran World Relief Health Kits, Layettes Enroute to Haiti; More Quilts and Kits Needed 2Health News:Lutheran World Relief Health Kits, Layettes Enroute to Haiti; More Quilts and Kits Needed 3Health News:Register Now for The Pro Expo(TM) Presented by Pella 2Health News:Register Now for The Pro Expo(TM) Presented by Pella 3Health News:In a Cross-Country Comeback, Skier With Type 1 Diabetes Named to U.S. Olympic Team 2Health News:In a Cross-Country Comeback, Skier With Type 1 Diabetes Named to U.S. Olympic Team 3Health News:In a Cross-Country Comeback, Skier With Type 1 Diabetes Named to U.S. Olympic Team 4Health News:Scientists show how brain tumors outsmart drugs 2
(Date:8/29/2014)... 29, 2014 Research and Markets ... Cancer Therapeutics Market & Pipeline Insight 2014" report ... developed to prevent and eradicate the prevalence of cancer ... are confined to low specificity, safety and large number ... for a better solution. It has been discovered that ...
(Date:8/29/2014)... SPRING, Md. , Aug. 29, 2014  United ... that the U.S. District Court for the District of ... its favor in the company,s case against Sandoz, Inc. ... Judge Peter Sheridan ruled that U.S. Patent ... Inc., and enjoined Sandoz from marketing its generic product ...
(Date:8/29/2014)... Aug. 29, 2014 /PRNewswire-iReach/ -- ChemImage will present a ... and New Zealand Forensic Science Society,s 22 nd ... Adelaide, Australia .  Forensic Scientists ... advancements that hyperspectral imaging can bring to examination ... , Director of Product Development at ChemImage, will ...
Breaking Medicine Technology:Global Peptide Cancer Therapeutics Market & Pipeline Insight 2014 2District Court Decision Received In Remodulin Patent Case 2ChemImage to Discuss Hyperspectral Imaging for Forensic Investigation at the ANZFSS 22nd International Symposium on the Forensic Sciences 2ChemImage to Discuss Hyperspectral Imaging for Forensic Investigation at the ANZFSS 22nd International Symposium on the Forensic Sciences 3